Dole plc Earnings Call Transcripts
Fiscal Year 2026
-
Q3 Adjusted EBITDA rose 4.1% to $84.1 million, while net leverage declined to 1.3x. FY2026 EBITDA guidance was cut to $380 million-$390 million, mainly on fuel inflation and weather-related supply pressures.
-
Revenue grew 2.9% to $2.5B, but profitability was pressured by higher Fresh Fruit costs. Strategic moves included a $95M port sale and a Scandinavian acquisition. Full-year Adjusted EBITDA guidance is $400M, with a stronger second half expected.
-
Consistent demand for fresh produce is supported by health trends and innovation, while inflationary and fuel cost pressures are managed through dynamic pricing and operational efficiencies. Asset optimization and targeted M&A continue, with profitability expected to improve in the second half of the year.
-
Q1 2026 saw 12% revenue growth and $100M adjusted EBITDA, with strong demand and positive FX, but higher fruit sourcing and input costs. Full-year adjusted EBITDA guidance remains at $400M, with H2 expected to be stronger as pricing and cost initiatives take effect.
Fiscal Year 2025
-
Strong 2025 results with Adjusted EBITDA of $395M, driven by growth in core segments and strategic asset sales. 2026 guidance targets at least $400M EBITDA, with normalized free cash flow and continued focus on operational efficiencies and capital allocation.
-
Q3 2025 saw strong revenue growth and resilient performance in diversified segments, offsetting fresh fruit cost headwinds. Strategic moves included the sale of the vegetable division, a $100M share buyback, and the launch of a premium pineapple. Full-year EBITDA is expected at the upper end of guidance.
-
Q2 2025 saw revenue rise 14.3% to $2.4B and adjusted EBITDA up 9.3% to $137M, driven by strong fresh produce performance. The sale of the vegetable division enhances strategic focus, with guidance raised for full-year adjusted EBITDA to $380–$390M.
-
Q1 2025 saw like-for-like revenue growth and resilient segment performance despite FX and weather headwinds. Full-year adjusted EBITDA guidance was raised to at least $380 million, and the dividend increased by 6.25%.
Fiscal Year 2024
-
Delivered record 2024 results with 6.7% like-for-like revenue and Adjusted EBITDA growth, reduced net debt, and strong segment performance. 2025 guidance anticipates a modest EBITDA decline due to storm impacts and normalization, with continued focus on capital discipline and growth opportunities.
-
Revenue grew 1% (5.8% like-for-like) and Adjusted EBITDA rose 2.3% like-for-like, led by strong Diversified Americas results. Full-year Adjusted EBITDA guidance was raised to at least $380 million, with continued focus on capital allocation and fleet expansion.
-
The summit highlighted strong recent performance, effective risk management, and ongoing investment in scale, technology, and core business growth. Management sees continued tailwinds from health trends and retailer investment, while focusing on margin, debt reduction, and selective M&A.
-
Q2 2024 saw strong like-for-like revenue and EBITDA growth, with net income up significantly year-over-year. Full-year adjusted EBIT guidance was raised to at least $370 million, and leverage fell to 1.9x, supported by robust segment performance and disciplined capital allocation.